Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Effcacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial.
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 배상철 | - |
| dc.date.accessioned | 2021-08-02T10:32:38Z | - |
| dc.date.available | 2021-08-02T10:32:38Z | - |
| dc.date.issued | 2019-11-09 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/12177 | - |
| dc.title | Effcacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial. | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | The 83th ACR meeting | - |
| dc.citation.conferencePlace | Atlanta, GA, | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.